222 related articles for article (PubMed ID: 24427322)
1. Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats.
Fan B; Ma L; Li Q; Wang L; Zhou J; Wu J
Int J Clin Exp Pathol; 2014; 7(1):16-27. PubMed ID: 24427322
[TBL] [Abstract][Full Text] [Related]
2. Correlation between platelet-derived growth factor signaling pathway and inflammation in desoxycorticosterone-induced salt-sensitive hypertensive rats with myocardial fibrosis.
Fan B; Ma L; Li Q; Wang L; Zhou J; Wu J
Int J Clin Exp Pathol; 2013; 6(11):2468-75. PubMed ID: 24228109
[TBL] [Abstract][Full Text] [Related]
3. Imatinib attenuates myocardial fibrosis in association with inhibition of the PDGFRα activity.
Ma LK; Li Q; He LF; Hua JS; Zhou JL; Yu H; Feng KF; Chen HW; Hu H; Wang L
Arq Bras Cardiol; 2012 Dec; 99(6):1082-91. PubMed ID: 23184075
[TBL] [Abstract][Full Text] [Related]
4. Role of PDGFR-β/PI3K/AKT signaling pathway in PDGF-BB induced myocardial fibrosis in rats.
Fan H; Ma L; Fan B; Wu J; Yang Z; Wang L
Am J Transl Res; 2014; 6(6):714-23. PubMed ID: 25628782
[TBL] [Abstract][Full Text] [Related]
5. Fasudil attenuates myocardial fibrosis in association with inhibition of monocyte/macrophage infiltration in the heart of DOCA/salt hypertensive rats.
Ishimaru K; Ueno H; Kagitani S; Takabayashi D; Takata M; Inoue H
J Cardiovasc Pharmacol; 2007 Aug; 50(2):187-94. PubMed ID: 17703135
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
7. RNA interference against platelet-derived growth factor receptor α mRNA inhibits fibroblast transdifferentiation in skin lesions of patients with systemic sclerosis.
Liu T; Zhang J; Zhang J; Mu X; Su H; Hu X; Liu W; Zhao E; Li W
PLoS One; 2013; 8(4):e60414. PubMed ID: 23577108
[TBL] [Abstract][Full Text] [Related]
8. Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart.
Sarzani R; Arnaldi G; Chobanian AV
Hypertension; 1991 Jun; 17(6 Pt 2):888-95. PubMed ID: 1646170
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
10. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
Lyu B; Wang W; Ji XY; Ritter JK; Li N
BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
[TBL] [Abstract][Full Text] [Related]
11. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
Kagitani S; Ueno H; Hirade S; Takahashi T; Takata M; Inoue H
J Hypertens; 2004 May; 22(5):1007-15. PubMed ID: 15097242
[TBL] [Abstract][Full Text] [Related]
12. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
14. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8087-8094. PubMed ID: 31599435
[TBL] [Abstract][Full Text] [Related]
15. Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism.
Ma L; Hua J; He L; Li Q; Zhou J; Yu J
Bosn J Basic Med Sci; 2012 May; 12(2):69-73. PubMed ID: 22642589
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor involvement in myocardial remodeling following infarction.
Zhao W; Zhao T; Huang V; Chen Y; Ahokas RA; Sun Y
J Mol Cell Cardiol; 2011 Nov; 51(5):830-8. PubMed ID: 21767547
[TBL] [Abstract][Full Text] [Related]
17. Selective delivery of IFN-γ to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis.
Poosti F; Bansal R; Yazdani S; Prakash J; Post E; Klok P; van den Born J; de Borst MH; van Goor H; Poelstra K; Hillebrands JL
FASEB J; 2015 Mar; 29(3):1029-42. PubMed ID: 25466892
[TBL] [Abstract][Full Text] [Related]
18. PDGF-BB induces conversion, proliferation, migration, and collagen synthesis of oral mucosal fibroblasts through PDGFR-β/PI3K/ AKT signaling pathway.
Wang J; You J; Gong D; Xu Y; Yang B; Jiang C
Cancer Biomark; 2021; 30(4):407-415. PubMed ID: 33492283
[TBL] [Abstract][Full Text] [Related]
19. Effect of imatinib on DOCA-induced myocardial fibrosis in rats through P38 MAPK signaling pathway.
Dong B; Chen DF; Bu XH; Qin HB; Xi Y
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2028-2036. PubMed ID: 32141572
[TBL] [Abstract][Full Text] [Related]
20. Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.
Wang LX; Yang X; Yue Y; Fan T; Hou J; Chen GX; Liang MY; Wu ZK
PLoS One; 2017; 12(6):e0178619. PubMed ID: 28570599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
